These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22857525)

  • 21. Interview with Dr Richard Barker, Director General of the Association of the British Pharmaceutical Industry.
    Barker R
    Future Med Chem; 2009 Jun; 1(3):421-6. PubMed ID: 21426122
    [No Abstract]   [Full Text] [Related]  

  • 22. Re-engineering drug discovery and development.
    FitzGerald GA
    LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preface of EuPAT 7 Special Issue - Inventing Tomorrow's Development and Manufacturing.
    Rantanen J; Khinast J
    Eur J Pharm Sci; 2016 Jul; 90():1. PubMed ID: 27324754
    [No Abstract]   [Full Text] [Related]  

  • 26. Searching for scalable processes: addressing the challenges in times of increasing complexity.
    Federsel HJ
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):838-47. PubMed ID: 14758755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput process development for biopharmaceutical drug substances.
    Bhambure R; Kumar K; Rathore AS
    Trends Biotechnol; 2011 Mar; 29(3):127-35. PubMed ID: 21255855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biotech products pose distribution challenges.
    Szeinbach SL; Gillenwater EL
    Am Pharm; 1994 Mar; NS34(3):19-20. PubMed ID: 8192094
    [No Abstract]   [Full Text] [Related]  

  • 29. R&D technology investments: misguided and expensive or a better way to discover medicines?
    Schmid EF; Smith DA
    Drug Discov Today; 2006 Sep; 11(17-18):775-84. PubMed ID: 16935744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 31. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

  • 33. An optical method for continuous monitoring of the dissolution rate of pharmaceutical powders.
    Laitinen R; Lahtinen J; Silfsten P; Vartiainen E; Jarho P; Ketolainen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):181-9. PubMed ID: 20116958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Precision and accuracy in production processes].
    Cattaneo A; Merli S
    Boll Chim Farm; 1969 Mar; 108(3):145-51. PubMed ID: 5806404
    [No Abstract]   [Full Text] [Related]  

  • 35. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of the near-infrared spectroscopy in the pharmaceutical technology.
    Jamrógiewicz M
    J Pharm Biomed Anal; 2012 Jul; 66():1-10. PubMed ID: 22469433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why We Need Continuous Pharmaceutical Manufacturing and How to Make It Happen.
    Badman C; Cooney CL; Florence A; Konstantinov K; Krumme M; Mascia S; Nasr M; Trout BL
    J Pharm Sci; 2019 Nov; 108(11):3521-3523. PubMed ID: 31381905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organic solvents in the pharmaceutical industry.
    Grodowska K; Parczewski A
    Acta Pol Pharm; 2010; 67(1):3-12. PubMed ID: 20210074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of chemistry for the future of the pharma industry.
    Wild H; Heimbach D; Huwe C
    Angew Chem Int Ed Engl; 2011 Aug; 50(33):7452-3. PubMed ID: 21818828
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bioengineering, pharmaceutical development and control of contamination: the three components of pharmaceutical engineering and their influence in advanced methods of production].
    Ghirardini M; Falini R
    Boll Chim Farm; 1986 Sep; 125(9):328-38. PubMed ID: 3828099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.